PRODUCT PHYSICAL CONSISTENCY ISSUE

This adverse event was reported 5540 times

These drugs are most commonly taken by patients reporting PRODUCT PHYSICAL CONSISTENCY ISSUE:

# Drug Count
0 LEUPROLIDE ACETATE 957
1 CLASCOTERONE 329
2 BUPRENORPHINE 192
3 RUXOLITINIB 136
4 CHOLESTYRAMINE 135
5 NAPROXEN SODIUM 117
6 NAPROXEN SODIUM TABLET 105
7 TESTOSTERONE 98
8 NALTREXONE 95
9 MINOXIDIL 91
See all common drugs associated with PRODUCT PHYSICAL CONSISTENCY ISSUE

PRODUCT PHYSICAL CONSISTENCY ISSUE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CLASCOTERONE 329 0.2319
1 ERYTHROMYCIN AND BENZOYL PEROXIDE 11 0.0679
2 SINCALIDE 7 0.0458
3 12%AZELAIC ACID 29 0.0346
4 AZELAIC ACID 32 0.0324
5 NATAMYCIN 9 0.0220
6 MINERAL OIL AND WHITE PETROLATUM 8 0.0154
7 ARIPIPRAZOLE LAUROXIL 68 0.0148
8 BESIFLOXACIN 12 0.0124
9 LEUPROLIDE ACETATE 957 0.0122
See all drugs enriched for association with PRODUCT PHYSICAL CONSISTENCY ISSUE

PRODUCT PHYSICAL CONSISTENCY ISSUE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Cholecystokinin Analog [EPC] 7 0.0458
1 Polyene Antimicrobial [EPC] 9 0.0220
2 l-Thyroxine [EPC] 1 0.0204
3 l-Triiodothyronine [EPC] 1 0.0196
4 Bile Acid Sequestrant [EPC] 135 0.0110
5 Sucrose-specific Enzyme [EPC] 1 0.0055
6 Melanin Synthesis Inhibitor [EPC] 6 0.0053
7 Surfactant [EPC] 6 0.0052
8 Androgen Receptor Inhibitor [EPC] 351 0.0047
9 Pyrethroid [EPC] 8 0.0045
See all drug classes enriched for association with PRODUCT PHYSICAL CONSISTENCY ISSUE